TGFB1 and metabolic disease: It has been reported that kaempferol-7-O-methylether, another major component, may increase the activity of PPAR-γ and inhibit the TGF-β pathway, thus improving the metabolic disorder and ovarian fibrosis in PCOS rats (34).